Philadelphia, PA · Founded 2023 · Privately Held (backing)
Developer of biological and small-molecule treatments designed for metabolic disease management. Alveus Therapeutics is based in Philadelphia, PA and was founded in 2023. It was valued at $275 million at its early-stage round in Feb 2026, the last priced event on record. It has raised $202 million across 1 recorded round; the latest was a $56.9 million later-stage round in Dec 2025.
These 13 firms already write checks for companies like Alveus Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.